Hikma Pharmaceuticals (OTCMKTS:HKMPY) Trading 2% Higher – What’s Next?

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price was up 2% on Tuesday . The company traded as high as $39.8270 and last traded at $39.8270. Approximately 401 shares traded hands during trading, a decline of 72% from the average daily volume of 1,423 shares. The stock had previously closed at $39.05.

Hikma Pharmaceuticals Price Performance

The firm has a 50 day moving average of $38.75 and a 200-day moving average of $39.13.

About Hikma Pharmaceuticals

(Get Free Report)

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.

Featured Articles

• Five stocks we like better than Hikma Pharmaceuticals
• MDA Space Targets US Defense Market With $620M Acquisition
• Carnival’s Second Quarter: Is the Stock Still Complicated?
• Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
• Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal